<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SSTi-SZGD_Demonstrate skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SSTi-SZGD/Demonstrate</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><HEADER class="container-fluid page_header fadeIn animated"><DIV class="container transition"><NAV class="page_nav col-xs-12 collapse navbar-collapse" id="example-navbar-collapse"><UL class="nav navbar-nav"><LI class="active"><A href="https://2018.igem.org/Team:SSTi-SZGD">Home</A></LI><LI><A href="https://2018.igem.org/Team:SSTi-SZGD/Description">Project</A></LI><LI><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:SSTi-SZGD/Applied_Design">Application</A></LI><LI><A href="https://2018.igem.org/Team:SSTi-SZGD/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:SSTi-SZGD/Team">Acknowledgements</A></LI></UL></NAV><NAV class="sub_nav col-xs-12"><UL class="container"><LI class="col-xs-12 Project"><A href="https://2018.igem.org/Team:SSTi-SZGD/Description">Description</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Design">Design</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Results">Results</A><A href="https://2018.igem.org/Team:SSTi-SZGD/InterLab">InterLab</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Protocols">Protocols</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Safety">Safety</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Notebook">Notebook</A></LI><LI class="col-xs-12 Parts"><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#All_parts">All Parts</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Basic_part">Basic Part</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Composite_part">Composite Part</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Improved_part">Improved Biobrick</A></LI><LI class="col-xs-12 Application"><A href="https://2018.igem.org/Team:SSTi-SZGD/Applied_Design">Applied Design</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Entrepreneurship">Entrepreneurship</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Demonstrate">Demonstrate</A></LI><LI class="col-xs-12 Human_Practices"><A href="https://2018.igem.org/Team:SSTi-SZGD/Human_Practices">Integrated Human Practices</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Public_Engagement">Public Engagement &amp; Out Reach</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Awards">Awards</A></LI><LI class="col-xs-12 Acknowledgements"><A href="https://2018.igem.org/Team:SSTi-SZGD/Team">Team</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Collaborations">Collaborations</A><A href="https://2018.igem.org/Team:SSTi-SZGD/Attributions">Attributions</A></LI></UL></NAV></DIV></HEADER><DIV class="page_content"><DIV class="container Content"><SECTION class="col-xs-12 col-sm-10"><DIV class="content"><P>
							From the <A href="https://2018.igem.org/Team:SSTi-SZGD/Human_Practices">integrated human practices</A>
							, we understand that there is a need for safer and more effective methods for anti-aging and wrinkle removal purpose. Therefore, the way to meet these requirements is the goal of our project. We started our project by biosynthesis of a substance, hyaluronic acid (HA), which is commonly used in preparing dermal fillers in plastic surgery via synthetic biology engineering, then we developed a safe and effective anti-wrinkle product--HA microneedle. Our methods for HA biosynthesis is via using a food grade safe strain, <I>B.subtilis</I>
							, which has indigenous synthetic pathway for the biosynthesis of HA precursors. By cloning a HA synthase gene from <I>Streptococcus zooepidermicus</I>
							, we obtained an engineered <I>B. subtilis</I>
							 strain that is able to biosynthesize HA. We managed to increase HA production level by regulating some of the precursor genes in the upstream synthetic pathway. Furthermore, we cloned a leech HA hydrolytic gene into the engineered<I>B.subtilis</I> 
							 strain so that low molecular weight HA can be produced for the purpose of microneedle fabrication. By covalently cross-linking HA molecules, a stabilized hydrogel is obtained that serves the starting material for microneedle production. </P></DIV></SECTION><SECTION class="achieved col-xs-12 col-sm-10"><P class="title"><SPAN>What we have achieved?</SPAN></P><DIV class="content"><P>
							In summary, we demonstrate that in this project we achieved the following results</P><UL><LI>We successfully constructed a recombinant B.subtilis 168E strain that secretes high-molecular-weight HA. In addition, by overexpressing some of the precursors gene in the HA synthesis pathway, HA production level was elevated.</LI><LI>We further obtained a recombinant B.subtilis 168 strain that directly secretes low-molecular-weight HA in large quantity by cloning leech HA hydrolase LHAyal gene.</LI><LI>Using our purified and freeze-dried HA powder, we successfully fabricated HA microneedles that is an innovative design in dermal filler development.</LI></UL></DIV></SECTION><SECTION class="note col-xs-12 col-sm-10"><DIV class="card_title"><DIV class="col-xs-3 active"><SPAN>① High-molecular weight HA</SPAN></DIV><DIV class="col-xs-3"><SPAN>② Leech hyaluronidase</SPAN></DIV><DIV class="col-xs-3"><SPAN>③ Low-molecular-weight HA</SPAN></DIV><DIV class="col-xs-3"><SPAN>④ HA microneedles</SPAN></DIV></DIV><DIV class="content card_content"><P>
							We successfully constructed a recombinant<I>B.subtilis</I>
							168E strain, containing a HA synthase (<I>hasA</I>
							) gene, to produce HMW-HA, and overexpressed some of the precursor genes (<I>tuaD, gtaB, glmU</I>
							) obtained from the HA synthesis pathway. CTAB methods verified that overexpression of the precursor genes further helped increasing HA production. Molecular weight analysis showed that the increase of HA yield did not affect the molecular weight. We also purified and freeze-dried our HA product!</P><DIV class="img"><DIV class="col-xs-12 col-sm-4"><P>
									Effects of 
									<I>hasA</I> 
									and precursors genes on HA production
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
									Molecular weight analysis of HA products
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
									Our purified and freeze-dried HA powder
								</P></DIV></DIV></DIV><DIV class="content card_content"><P>
							We successfully expressed recombinant leech hyaluronidase (<I>LHAyal</I>
							) in<I>B. subtilis</I>
							 168. Enzyme activity of LHAase was visualized using a HA agarose plate assay and verified by DNS reducing sugar assay. With its confirmed hydrolase activity, we were one step closer to in vivo hydrolysis of high molecular weight HA.</P><DIV class="img"><DIV class="col-xs-12 col-sm-4"><P>
									LHAase enzyme activity analysis (DNS reducing sugar)
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
									LHAase enzyme activity vs. Bacterial growth
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
									LHAase enzyme activity visualized by HA agarose plate
								</P></DIV></DIV></DIV><DIV class="content card_content"><P>
							We cloned leech LHAyal gene into the recombinant<I>B.subtilis</I>
							 168E strain and successfully made it hydrolyzing HMW-HA to become LMW-HA. Reduction in the molecular weight of HA was confirmed by gel chromatography (GPC-RI-MALS). CTAB results showed an increasing LMW-HA concentrations, reflecting a decrease of the viscosity of the fermentation liquid. Therefore, we successfully produced LMW-HA in<I>B.subtilis</I>
							 !</P><DIV class="img"><DIV class="col-xs-12 col-sm-6"><P>
									Molecular weight analysis of hydrolyzing HA
								</P></DIV><DIV class="col-xs-12 col-sm-6"><P>
									Analysis of HMW-HA and LMW-HA concentrations
								</P></DIV></DIV></DIV><DIV class="content card_content"><P>
					    	We covalently cross-linked HA molecules (cHA) to make hydrogel powder, and designed a specially crafted micromold. By decoding the optimal weight ratio of HA-cHA (5:1) to make a hydrogel mixture, we successfully fabricated a HA microneedle patch with good mechanical strength for skin epidermal penetration.</P><DIV class="img"><DIV class="col-xs-12 col-sm-4"><P>
									The cross-linked HA hydrogel powder
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
									Demoulding of HA microneedle patch after overnight curing
								</P></DIV><DIV class="col-xs-12 col-sm-4"><P>
								    Display of our HA microneedles!
								</P></DIV></DIV></DIV></SECTION><SECTION class="col-xs-12 col-sm-10"><P class="title"><SPAN>Summary</SPAN></P><DIV class="content"><P>
							To conclude, we successfully obtained three HA products with commercial values via synthetic engineering approach, and managed to obtain a miniature of the innovated cosmetic product--HA microneedles--that has a great potential in future beauty industry!</P></DIV></SECTION></DIV></DIV><SECTION class="btn_nav animated"><UL class="container"><LI class="col-xs-12 Navigation"><DL><DT>Navigation</DT></DL></LI><LI class="col-xs-12 Home"><DL><DT><A href="https://2018.igem.org/Team:SSTi-SZGD">Home</A></DT></DL></LI><LI class="col-xs-12 Project"><DL><DT>Project</DT><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Description">Description</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Design">Design</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Results">Results</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/InterLab">InterLab</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Protocols">Protocols</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Safety">Safety</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Notebook">Notebook</A></DD></DL></LI><LI class="col-xs-12 Parts"><DL><DT>Parts</DT><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#All_parts">All Parts</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Basic_part">Basic Part</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Composite_part">Composite Part</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Parts#Improved_part">Improved Biobrick</A></DD></DL></LI><LI class="col-xs-12 Application"><DL><DT>Application</DT><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Applied_Design">Applied Design</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Entrepreneurship">Entrepreneurship</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Demonstrate">Demonstrate</A></DD></DL></LI><LI class="col-xs-12 Human_Practices"><DL><DT>Human Practices</DT><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Human_Practices">Integrated Human Practices</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Public_Engagement">Public Engagement &amp; Out Reach</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Awards">Awards</A></DD></DL></LI><LI class="col-xs-12 Acknowledgements"><DL><DT>Acknowledgements</DT><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Team">Team</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Collaborations">Collaborations</A></DD><DD><A href="https://2018.igem.org/Team:SSTi-SZGD/Attributions">Attributions</A></DD></DL></LI></UL><DIV class="container-fluid btn_copyright">Copyright © 2018 SSTi-SZGD All Rights Reserved.</DIV></SECTION><FOOTER class="container-fluid page_footer"><SECTION class="container-fluid page_copyright">
				
				Copyright © 2018 SSTi-SZGD All Rights Reserved.
				
			</SECTION></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>